Metabolic syndrome and renal injury

Cardiology Research and Practice

Volumn 1, Issue 1, 2011, Pages

  Sheu, Wayne Huey Herng ^b   Sheen, Yi Jing ^a  

^a TAICHUNG HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYSTATIN C; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INTERLEUKIN 6; LEPTIN; LIPID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN; RESISTIN; SIBUTRAMINE; STATIN; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ALBUMINURIA; BARIATRIC SURGERY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; ENZYME ACTIVATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INCIDENCE; KIDNEY INJURY; METABOLIC SYNDROME X; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; WEIGHT CONTROL;

EID: 79959390434     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2011/567389     Document Type: Review

References (114)

1. Pei D., Kuo S. W., Wu D. A., Lin T. Y., Hseih M. C., Lee C. H., Hsu W. L., Chen S. P., Sheu W. H. H., Li J. C., The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians International Journal of Clinical Practice 2005 59 12 1408 1416 (Pubitemid 43922627)
2. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statementexecutive summary Critical Pathways in Cardiology 2005 4 4 198 203 (Pubitemid 41697502)
3. Sheu W. H. H., Chuang S. Y., Lee W. J., Tsai S. T., Chou P., Chen C. H., Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan Diabetes Research and Clinical Practice 2006 74 2 162 168 (Pubitemid 44764897)
4. Iglesias P., Dez J. J., Adipose tissue in renal disease: clinical significance and prognostic implications Nephrology Dialysis Transplantation 2010 25 7 2066 2077
5. Rosito G. A., Massaro J. M., Hoffmann U., Ruberg F. L., Mahabadi A. A., Vasan R. S., O'Donnell C. J., Fox C. S., Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample the framingham heart study Circulation 2008 117 5 605 613
6. Lee I. T., Huang C. N., Lee W. J., Lee H. S., Sheu W. H. H., Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects Diabetes Research and Clinical Practice 2008 81 3 345 350
7. Lucove J., Vupputuri S., Heiss G., North K., Russell M., Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study American Journal of Kidney Diseases 2008 51 1 21 28 (Pubitemid 350296515)
8. Chang C. H., Shau W. Y., Jiang Y. D., Li H. Y., Chang T. J., H.-H. Sheu W. W., Kwok C. F., Ho L. T., Chuang L. M., Type 2 diabetes prevalence and incidence among adults in Taiwan during 19992004: a national health insurance data set study Diabetic Medicine 2010 27 6 636 643
9. Savino A., Pelliccia P., Chiarelli F., Mohn A., Obesity-related renal injury in childhood Hormone Research in Paediatrics 2010 73 5 303 311
10. Prasad S. B., Prevalence, detection, and management of the metabolic syndrome in patients with acute myocardial infarction: role of an obesity-centric definition Cardiology Research and Practice 2010 2010 7
11. Wang Y., Chen X., Klag M. J., Caballero B., Epidemic of childhood obesity: implications for kidney disease Advances in Chronic Kidney Disease 2006 13 4 336 351 (Pubitemid 44512238)
12. Sun F., Tao Q., Zhan S., Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort: original Article Nephrology 2010 15 1 84 92
13. Hoehner C. M., Greenlund K. J., Rith-Najarian S., Casper M. L., McClellan W. M., Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project Journal of the American Society of Nephrology 2002 13 6 1626 1634 (Pubitemid 34579251)
14. Chen J., Muntner P., Hamm L. L., Jones D. W., Batuman V., Fonseca V., Whelton P. K., He J., The metabolic syndrome and chronic kidney disease in U.S. adults Annals of Internal Medicine 2004 140 3 167 I39
15. Chou C. L., Fang TE. C., Incidental chronic kidney disease in metabolic syndrome Tzu Chi Medical Journal 2010 22 1 11 17
16. Kundhal K., Lok C. E., Clinical epidemiology of cardiovascular disease in chronic kidney disease NephronClinical Practice 2005 101 2 c47 c52
17. Ryu S., Chang Y., Woo H. Y., Lee K. B., Kim S. G., Kim D. I., Kim W. S., Suh B. S., Jeong C., Yoon K., Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes American Journal of Kidney Diseases 2009 53 1 59 69
18. Chawla V., Greene T., Beck G. J., Kusek J. W., Collins A. J., Sarnak M. J., Menon V., Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease Clinical Journal of the American Society of Nephrology 2010 5 9 1582 1587
19. Lea J., Cheek D., Thornley-Brown D., Appel L., Agodoa L., Contreras G., Gassman J., Lash J., Miller E. R., Randall O., Wang X., McClellan W., Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans American Journal of Kidney Diseases 2008 51 5 732 740 (Pubitemid 351626250)
20. Muntner P., Coresh J., Smith J. C., Eckfeldt J., Klag M. J., Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney International 2000 58 1 293 301 (Pubitemid 30429874)
21. Zoccali C., Overweight, obesity and metabolic alterations in chronic kidney disease Prilozi 2009 30 2 17 31
22. Kurella M., Lo J. C., Chertow G. M., Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults Journal of the American Society of Nephrology 2005 16 7 2134 2140 (Pubitemid 41716445)
23. Choi H. S., Ryu S. H., Lee K. B., The relationship of microalbuminuria with metabolic syndrome NephronClinical Practice 2006 104 2 c85 c93
24. Ninomiya T., Kiyohara Y., Kubo M., Yonemoto K., Tanizaki Y., Doi Y., Hirakata H., Iida M., Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study American Journal of Kidney Diseases 2006 48 3 383 391 (Pubitemid 44247252)
25. Tanaka H., Shiohira Y., Uezu Y., Higa A., Iseki K., Metabolic syndrome and chronic kidney disease in Okinawa, Japan Kidney International 2006 69 2 369 374 (Pubitemid 43323089)
26. Chen J., Gu D., Chen C. S., Wu X., Hamm L. L., Muntner P., Batuman V., Lee C. H., Whelton P. K., He J., Association between the metabolic syndrome and chronic kidney disease in Chinese adults Nephrology Dialysis Transplantation 2007 22 4 1100 1106 (Pubitemid 46523424)
27. Hao Z., Konta T., Takasaki S., Abiko H., Ishikawa M., Takahashi T., Ikeda A., Ichikawa K., Kawata S., Kato T., Kubota I., The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study Internal Medicine 2007 46 7 341 346 (Pubitemid 46585471)
28. Rashidi A., Ghanbarian A., Azizi F., Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population Clinical Journal of the American Society of Nephrology 2007 2 5 976 983
29. Tozawa M., Iseki C., Tokashiki K., Chinen S., Kohagura K., Kinjo K., Takishita S., Iseki K., Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults Hypertension Research 2007 30 10 937 943 (Pubitemid 350120971)
30. Zhang L., Zuo L., Wang F., Wang M., Wang S., Liu L., Wang H., Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older Mayo Clinic Proceedings 2007 82 7 822 827 (Pubitemid 47015461)
31. Kawamoto R., Kohara K., Tabara Y., Miki T., An association between metabolic syndrome and the estimated glomerular filtration rate Internal Medicine 2008 47 15 1399 1406
32. Luk A. O. Y., So W. Y., Ma R. C. W., Kong A. P. S., Ozaki R., Ng V. S. W., Yu L. W. L., Lau W. W. Y., Yang X., Chow F. C. C., Chan J. C. N., Tong P. C. Y., Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes A 5-year prospective analysis of the Hong Kong diabetes registry Diabetes Care 2008 31 12 2357 2361
33. Reaven G. M., Role of insulin resistance in human disease Diabetes 1988 37 12 1595 1607 (Pubitemid 19004941)
34. Tsai H.-J., Hsiao C.-F., Ho L.-T., Chuang L.-M., He C.-T., Curb J. D., Quertermos T., Hsiung C. A., Sheu W. H.-H., Genetic variants of human urea transporter-2 are associated with metabolic syndrome in Asian population Clinica Chimica Acta 2010 411 23-24 2009 2013
35. Chang YI. C., Chiu Y. F., Shih K. C., Lin M. W., Sheu W. H. H., Donlon T., Curb J. D., Jou Y. S., Chang T. J., Li H. Y., Chuang L. M., Common PCSK1 haplotypes are associated with obesity in the Chinese population Obesity 2010 18 7 1404 1409
36. Sheu W. H. H., Chen Y. D. I., Yu C. Y., Guo X., Lee T. C., Lee W. J., Chen Y. T., Rotter J. I., C-reactive protein gene polymorphism 1009A G is associated with serum CRP levels in Chinese men: a TCVGHAGE study Clinica Chimica Acta 2007 382 1-2 117 123 (Pubitemid 46782749)
37. Wu K. D., Hsiao C. F., Ho L. T., Sheu W. H. H., Pei D., Chuang L. M., Curb D., Chen Y. D. I., Tsai H. J., Dzau V. J., Cox D., Tai T. Y., Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in hypertension and insulin resistance sibling study Hypertension Research 2002 25 4 529 536
38. Alberti K. G. M. M., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabetic Medicine 1998 15 7 539 553 (Pubitemid 28319935)
39. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Journal of the American Medical Association 2001 285 19 2486 2497 (Pubitemid 32433843)
40. Alberti K. G. M. M., Zimmet P., Shaw J., The metabolic syndromea new worldwide definition Lancet 2005 366 9491 1059 1062 (Pubitemid 41338752)
41. Lin C. C., Liu C. S., Li C. I., Lin W. Y., Lai M. M., Lin T., Chang P. C., Lee Y. D., Chen C. C., Lin C. H., Yang C. W., Hsiao C. Y., Chen W., Li T. C., The relation of metabolic syndrome according to five definitions to cardiovascular risk factorsa population-based study BMC Public Health 2009 9, article 484
42. Hsieh C. H., Hung YI. J., Wu DU. A., Kuo S. W., Lee C. H., Sheu W. H. H., Li J. C., Yeh K. H., Chen C. Y., Pei D., Impact of clinical characteristics of individual metabolic syndrome on the severity of insulin resistance in Chinese adults Journal of Korean Medical Science 2007 22 1 74 80
43. Lin S. Y., Sheu W. H. H., An emerging link between insulin resistance and inflammation Journal of the Chinese Medical Association 2006 69 6 245 247
44. Lin M. W., Hwu C. M., Huang Y. H., Sheu W. H. H., Shih K. C., Chiang FU. T., Olshen R., Chen Y. D. I., Curb J. D., Rodriguez B., Ho L. T., Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension American Journal of Hypertension 2006 19 11 1118 1124 (Pubitemid 44633588)
45. Chang C. H., Chen YI. M., Chuang YA. W., Liao S. C., Lin C. S., Tang Y. J., Sheu W. H. H., Chen D. Y., Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men Archives of Gerontology and Geriatrics 2009 49 supplement 2 S46 S49
46. Sung S. H., Chuang S. Y., Sheu W. H. H., Lee W. J., Chou P., Chen C. H., Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population American Journal of Cardiology 2009 103 10 1411 1416
47. Sheu W. H. H., Tseng Y. H., Uric acid: an additional component of metabolic syndrome? Journal of the Chinese Medical Association 2006 69 3 99 100
48. Chou Y. Y., Sheu W. H. H., Tang Y. J., Chen YI. M., Liao S. C., Chuang YA. W., Lin C. S., Chen D. Y., Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan Archives of Gerontology and Geriatrics 2009 49 supplement 2 S41 S45
49. Balkau B., Charles M. A., Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabetic Medicine 1999 16 5 442 443
50. Chen B., Yang D., Chen Y. U., Xu W., Ye BO., Ni Z., The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China Clinica Chimica Acta 2010 411 9-10 705 709
51. Ritz E., Metabolic syndrome and kidney disease Blood Purification 2008 26 1 59 62
52. Przybylowski P., Malyszko J., Malyszko J., Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients Medical Science Monitor 2010 16 9 CR440 CR444
53. Bagshaw S. M., Bellomo R., Cystatin C in acute kidney injury Current Opinion in Critical Care 2010 16 6 533 539
54. Vigil L., Lopez M., Condés E., Varela M., Lorence D., Garcia-Carretero R., Ruiz J., Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population Journal of the American Society of Hypertension 2009 3 3 201 209
55. Lee S. H., Park S. A., Ko S. H., Yim H. W., Ahn YU. B., Yoon K. H., Cha B. Y., Son HO. Y., Kwon H. S., Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients Metabolism 2010 59 2 241 246
56. Uchino S., Creatinine Current Opinion in Critical Care 2010 16 6 562 567
57. Parlongo G., Zoccali C., Obesity and chronic kidney diseaseL'obesit corne causa di insuff icienza renale Recenti Progressi in Medicina 2010 101 2 57 60
58. Coresh J., Astor B. C., Greene T., Eknoyan G., Levey A. S., Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey American Journal of Kidney Diseases 2003 41 1 1 12 (Pubitemid 36043346)
59. Whelton P. K., Perneger T. V., He J., Klag M. J., The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence Journal of Human Hypertension 1996 10 10 683 689 (Pubitemid 27037518)
60. Haroun M. K., Jaar B. G., Hoffman S. C., Comstock G. W., Klag M. J., Coresh J., Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland Journal of the American Society of Nephrology 2003 14 11 2934 2941 (Pubitemid 37305656)
61. Lee P. H., Chang H. Y., Tung C. W., Hsu Y. C., Lei C. C., Chang H. H., Yang H. F., Lu L. C., Jong M. C., Chen C. Y., Fang K. Y., Chao YU. S., Shih YA. H., Lin C. L., Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults American Journal of the Medical Sciences 2009 338 3 185 189
62. Halbesma N., Kuiken D. S., Brantsma A. H., Bakker S. J. L., Wetzels J. F. M., De Zeeuw D., De Jong P. E., Gansevoort R. T., Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening Journal of the American Society of Nephrology 2006 17 9 2582 2590 (Pubitemid 44300975)
63. Basi S., Lewis J. B., Microalbuminuria as a target to improve cardiovascular and renal outcomes American Journal of Kidney Diseases 2006 47 6 927 946 (Pubitemid 43767323)
64. Okura T., Jotoku M., Irita J., Enomoto D., Nagao T., Desilva V. R., Yamane S., Pei Z., Kojima S., Hamano Y., Mashiba S., Kurata M., Miyoshi K.-i., Higaki J., Association between cystatin C and inflammation in patients with essential hypertension Clinical and Experimental Nephrology 2010 14 6 584 588
65. Shlipak M. G., Katz R., Sarnak M. J., Fried L. F., Newman A. B., Stehman-Breen C., Seliger S. L., Kestenbaum B., Psaty B., Tracy R. P., Siscovick D. S., Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Annals of Internal Medicine 2006 145 4 237 246 (Pubitemid 46768607)
66. Menon V., Shlipak M. G., Wang X., Coresh J., Greene T., Stevens L., Kusek J. W., Beck G. J., Collins A. J., Levey A. S., Sarnak M. J., Cystatin C as a risk factor for outcomes in chronic kidney disease Annals of Internal Medicine 2007 147 1 19 27 (Pubitemid 351664630)
67. Surendar J., Indulekha K., Aravindhan V., Ganesan A., Mohan V., Association of cystatin-C with metabolic syndrome in normal glucose-tolerant subjects (CURES-97) Diabetes Technology and Therapeutics 2010 12 11 907 912
68. Manrique C., Lastra G., Gardner M., Sowers J. R., The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress Medical Clinics of North America 2009 93 3 569 582
69. Duan S. Z., Usher M. G., Mortensen R. M., PPARs: the vasculature, inflammation and hypertension Current Opinion in Nephrology and Hypertension 2009 18 2 128 133
70. Mishra P. K., Tyagi N., Sen U., Joshua I. G., Tyagi S. C., Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol Cardiovascular Diabetology 2010 9, article 49
71. Wesoly J., Sikorski K., Lee C.-K., Bluyssen H. A.R., Suppressor of cytokine signaling and accelerated atherosclerosis in kidney disease Acta Biochimica Polonica 2010 57 3 251 260
72. Wu Y., Liu Z., Xiang Z., Zeng C., Chen Z., Ma X., Li L., Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples Endocrinology 2006 147 1 44 50 (Pubitemid 43004261)
73. Lazar M. A., How obesity causes diabetes: not a tall tale Science 2005 307 5708 373 375 (Pubitemid 40139971)
74. Eddy A. A., Fogo A. B., Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action Journal of the American Society of Nephrology 2006 17 11 2999 3012 (Pubitemid 44707760)
75. Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., Okada T., Ohashi K., Hibuse T., Fujita K., Yasui A., Hiuge A., Kumada M., Kuriyama H., Shimomura I., Funahashi T., Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation Kidney International 2006 70 10 1717 1724 (Pubitemid 44684802)
76. Lubrano R., Travasso E., Raggi C., Guido G., Masciangelo R., Elli M., Blood pressure load, proteinuria and renal function in pre-hypertensive children Pediatric Nephrology 2009 24 4 823 831
77. Hopkins K., Bakris G. L., Hypertension goals in advanced-stage kidney disease Clinical Journal of the American Society of Nephrology 2009 4 supplement 1 S92 S94
78. Hallan S. I., Stevens P., Screening for chronic kidney disease: which strategy? Journal of Nephrology 2010 23 2 147 155
79. Collins A. J., Vassalotti J. A., Wang C., Li S., Gilbertson D. T., Liu J., Foley R. N., Chen S. C., Arneson T. J., Who Should Be Targeted for CKD Screening? Impact of Diabetes, Hypertension, and Cardiovascular Disease American Journal of Kidney Diseases 2009 53 supplement 3 S71 S77
80. Ou H.-C., Lee W.-J., Lee S.-D., Huang C.-Y., Chiu T.-H., Tsai K.-L., Hsu W.-C., Sheu W. H.H., Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway Toxicology and Applied Pharmacology 2010 248 2 134 143
81. Ou H. C., Chou F. P., Lin T. M., Yang C. H., Sheu W. H. H., Protective effects of eugenol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells Food and Chemical Toxicology 2006 44 9 1485 1495
82. Ou H. C., Chou F. P., Lin T. M., Yang C. H., Sheu W. H. H., Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells Chemico-Biological Interactions 2006 161 1 1 13
83. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial The Lancet 2010 376 9739 419 430
84. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet 1998 352 9131 837 853
85. Holman R. R., Paul S. K., Bethel M. A., Matthews D. R., Neil H. A. W., 10-Year follow-up of intensive glucose control in type 2 diabetes New England Journal of Medicine 2008 359 15 1577 1589
86. Sarafidis P. A., Bakris G. L., Protection of the kidney by thiazolidinediones: an assessment from bench to bedside Kidney International 2006 70 7 1223 1233 (Pubitemid 44435173)
87. Matsumoto T., Noguchi E., Ishida K., Kobayashi T., Yamada N., Kamata K., Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes American Journal of Physiology 2008 295 3 H1165 H1176
88. Finkelstein J., Joshi A., Hise M. K., Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III) American Journal of Kidney Diseases 2006 48 3 372 382 (Pubitemid 44262421)
89. Fredrickson S. K., Ferro T. J., Schutrumpf A. C., Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction Diabetes Care 2004 27 7 1754 1755 (Pubitemid 38857458)
90. Meckling K. A., Sherfey R., A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women Applied Physiology, Nutrition and Metabolism 2007 32 4 743 752
91. Filippatos T. D., Kiortsis D. N., Liberopoulos E. N., Georgoula M., Mikhailidis D. P., Elisaf M. S., Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study Current Medical Research and Opinion 2005 21 12, article 3219 1997 2006 (Pubitemid 41803111)
92. Hung Y. I. J., Chen Y. C., Pei D., Kuo S. W., Hsieh C. H., Wu L. Y., He C. T., Lee C. H., Fan S. C., Sheu W. H. H., Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes Diabetic Medicine 2005 22 8 1024 1030 (Pubitemid 41025999)
93. Lindholm., Bixo M., Bjrn I., Wlner-Hanssen P., Eliasson M., Larsson A., Johnson O., Poromaa I. S., Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial Fertility and Sterility 2008 89 5 1221 1228 (Pubitemid 351671719)
94. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., Ori Y., The effects of weight loss on renal function in patients with severe obesity Journal of the American Society of Nephrology 2003 14 6 1480 1486 (Pubitemid 36687049)
95. Ibrahim H. N., Weber M. L., Weight loss: a neglected intervention in the management of chronic kidney disease Current Opinion in Nephrology and Hypertension 2010 19 6 534 538
96. Navaneethan S. D., Yehnert H., Moustarah F., Schreiber M. J., Schauer P. R., Beddhu S., Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis Clinical Journal of the American Society of Nephrology 2009 4 10 1565 1574
97. Black H. R., Davis B., Barzilay J., Nwachuku C., Baimbridge C., Marginean H., Wright J. T., Basile J., Wong N. D., Whelton P., Dart R. A., Thadani U., Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) Diabetes Care 2008 31 2 353 360 (Pubitemid 351213350)
98. Fujita T., Ando K., Nishimura H., Ideura T., Yasuda G., Isshiki M., Takahashi K., Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease Kidney International 2007 72 12 1543 1549 (Pubitemid 350199443)
99. Miwa Y., Tsuchihashi T., Ohta Y., Tominaga M., Kawano Y., Sasaguri T., Ueno M., Matsuoka H., Antiproteinuric effect of cilnidipine in hypertensive japanese treated with renin-angiotensin-system inhibitorsa multicenter, open, randomized trial using 24-hour urine collection Clinical and Experimental Hypertension 2010 32 6 400 405
100. Appel L. J., Wright Jr. J. T., Greene T., Agodoa L. Y., Astor B. C., Bakris G. L., Cleveland W. H., Charleston J., Contreras G., Faulkner M. L., Gabbai F. B., Gassman J. J., Hebert L. A., Jamerson K. A., Kopple J. D., Kusek J. W., Lash J. P., Lea J. P., Lewis J. B., Lipkowitz M. S., Massry S. G., Miller E. R., Norris K., Phillips R. A., Pogue V. A., Randall O. S., Rostand S. G., Smogorzewski M. J., Toto R. D., Wang X., Intensive blood-pressure control in hypertensive chronic kidney disease New England Journal of Medicine 2010 363 10 918 929
101. Wright J. T., Bakris G., Greene T., Agodoa L. Y., Appel L. J., Charleston J., Cheek D., Douglas-Baltimore J. G., Gassman J., Glassock R., Hebert L., Jamerson K., Lewis J., Phillips R. A., Toto R. D., Middleton J. P., Rostand S. G., Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial Journal of the American Medical Association 2002 288 19 2421 2431 (Pubitemid 35340538)
102. Omae K., Ogawa T., Nitta K., Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease Heart and Vessels 2010 25 3 203 208
103. Matsui T., Yamagishi S. I., Ueda S., Fukami K., Okuda S., Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury In vitro Protein and Peptide Letters 2010 17 1 74 77
104. Kunz R., Friedrich C., Wolbers M., Mann J. F. E., Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease Annals of Internal Medicine 2008 148 1 30 48 (Pubitemid 351688350)
105. Ruan X., Zheng F., Guan Y., PPARs and the kidney in metabolic syndrome American Journal of Physiology 2008 294 5 F1032 F1047
106. Lee T. M., Su S. F., Tsai C. H., Effect of pravastatin on proteinuria in patients with well-controlled hypertension Hypertension 2002 40 1 67 73
107. Sheu W. H., Chen Y. T., Lee W. J., Improvement in endothelial dysfunction with LDL cholesterol level 80mg/dl in type 2 diabetic patients Diabetes Care 2001 24 8 1499 1501
108. Lee I. T., Lee W. J., Ou H. C., Huang C. N., Sheu W. H. H., Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia Metabolism 2009 58 3 416 420
109. Lee W. J., Lee W. L., Tang Y. J., Liang K. W., Chien YU. H., Tsou S. S., Sheu W. H. H., Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia Clinica Chimica Acta 2008 390 1-2 49 55
110. Lewis D., Haynes R., Landray M. J., Lipids in chronic kidney disease Journal of Renal Care 2010 36 1 27 33
111. Ronco C., Haapio M., House A. A., Anavekar N., Bellomo R., Cardiorenal syndrome Journal of the American College of Cardiology 2008 52 19 1527 1539
112. Bakris G., Vassalotti J., Ritz E., Wanner C., Stergiou G., Molitch M., Nesto R., Kaysen G. A., Sowers J. R., National kidney foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events Kidney International 2010 78 8 726 736
113. Iwashima Y., Horio T., Kamide K., Tokudome T., Yoshihara F., Nakamura S., Ogihara T., Rakugi H., Kawano Y., Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension American Journal of Hypertension 2010 23 3 290 298
114. Martins D., Renal dysfunction, metabolic syndrome and cardiovascular disease mortality Journal of Nutrition and Metabolism 2010 2010 8